Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin

被引：0
|
作者：
Arrigo, Richard
Samanta, Arun
Griffith, Shanthini
Parekh, Ravish M.
Korogodsky, Maria
Rao, Kiran V.
Fisher, Adrian
Wilson, Dorian
Klein, Kenneth M.
Koneru, Baburao
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [21] Preliminary treatment results of pegylated interferon alpha 2b and ribavirin in liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2b and ribavirin
    Neff, GW
    Montalbano, M
    Ozden, N
    Muslu, H
    Lee, YM
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Madariaga, J
    Levi, D
    Nashida, S
    Kato, T
    Schiff, E
    Tzakis, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 160 - 160
  • [22] Lead In Treatment with PEG Interferon and Ribavirin is Useful before Initiating Telaprevir in Liver Transplant Recipients with Recurrent Hepatitis C
    Nair, Satheesh
    Satapathy, Sanjaya
    Waters, Bradford
    HEPATOLOGY, 2013, 58 : 1052A - 1052A
  • [23] Hepatitis C and treatment with pegylated interferon and ribavirin
    Gotto, J
    Dusheiko, GM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (10): : 1874 - 1877
  • [24] Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: A Prospective Cohort Study
    Mukherjee, S
    Gilroy, RK
    McCashland, TM
    Schafer, DF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1478 - 1479
  • [25] Combination treatment with pegylated interferon A and ribavirin in potential renal transplant recipients with chronic hepatitis C infection.
    Donaldson, K
    Pall, A
    Dillon, J
    Henderson, I
    Walsh, S
    SCOTTISH MEDICAL JOURNAL, 2006, 51 (01) : 55 - 55
  • [26] Pegylated interferon-alpha2a/ribavirin treatment of recurrent hepatitis C after liver transplantation
    Dinges, S.
    Morard, I.
    Heim, M.
    Dufour, J.-F.
    Mullhaupt, B.
    Giostra, E.
    Clavien, P. -A.
    Mentha, G.
    Negro, F.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (01) : 33 - 39
  • [27] Ribavirin treatment facilitates weaning from immunosuppression in liver transplant recipients with recurrent hepatitis C
    Tisone, G
    Zazza, S
    Manzia, TM
    Ciceroni, C
    De Luca, L
    Angelico, M
    Casciani, CU
    LIVER TRANSPLANTATION, 2003, 9 (06) : C5 - C5
  • [28] Extended Treatment with Peg-Interferon and Ribavirin for Recurrent Hepatitis C after Liver Transplantation
    Tufail, Kashif
    Hashemi, Nikroo
    Azhar, Ashaur
    Feyssa, Eyob
    Niazi, Mumtaz
    Ortiz, Jorge
    Araya, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S94 - S94
  • [29] Preemptive therapy with combination of interferon and ribavirin in liver transplant recipients with hepatitis C
    Dono, Keizo
    Marubashi, Shigeru
    Kobayashi, Shogo
    Nagano, Hiroaki
    Monden, Morito
    TRANSPLANT INTERNATIONAL, 2007, 20 : 290 - 290
  • [30] Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C
    Firpi, RJ
    Abdelmalek, ME
    Soldevila-Pico, C
    Reed, A
    Hemming, A
    Howard, R
    Van der Werf, W
    Lauwers, G
    Liu, C
    Crawford, JM
    Davis, GL
    Nelson, DR
    LIVER TRANSPLANTATION, 2002, 8 (11) : 1000 - 1006
12345